#news #biotech Biogen’s $300M bet on Alzheimer’s tau drug flames out in phase 2

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Biogen’s $300M bet on Alzheimer’s tau drug flames out in phase 2 .Biogen’s $300M bet on Alzheimer’s tau drug flames out in phase 2
ntaylor
Thu, 06/17/2021 – 05:15

from FierceBiotech: Biotech https://ift.tt/3q56aAp